Pacira Pharmaceuticals Inc (PCRX)

Net profit margin

		Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019
Net income (ttm)	US$ in thousands	41,955	6,983	-4,568	-10,455	15,909	20,881	39,234	38,439	41,980	61,624	174,083	147,733	145,523	126,121	-10,085	-86	-11,016	2,157	7,604	7,438
Revenue (ttm)	US$ in thousands	638,707	621,403	618,553	613,360	627,091	646,604	609,214	577,203	541,534	491,997	489,092	436,030	429,647	421,097	408,298	435,397	421,026	393,717	372,480	353,983
Net profit margin		6.57%	1.12%	-0.74%	-1.70%	2.54%	3.23%	6.44%	6.66%	7.75%	12.53%	35.59%	33.88%	33.87%	29.95%	-2.47%	-0.02%	-2.62%	0.55%	2.04%	2.10%

December 31, 2023 calculation

Net profit margin = Net income (ttm) ÷ Revenue (ttm)
= $41,955K ÷ $638,707K
= 6.57%

The net profit margin of Pacira BioSciences Inc has shown fluctuations over the past eight quarters. In Q4 2023, the net profit margin stood at 6.22%, indicating that the company retained $0.0622 of every dollar of revenue as profit. This represented an improvement from the previous quarter's net profit margin of 1.05%. However, it is important to note that in the two preceding quarters (Q2 2023 and Q1 2023), the company experienced negative net profit margins of -0.68% and -1.56% respectively, indicating that the company's expenses exceeded its revenues during those periods.

Comparing the latest quarter's net profit margin with the same quarter in the prior year (Q4 2022), there has been a slight increase from 2.39% to 6.22%. It is also noteworthy that the net profit margin was relatively higher in the earlier quarters of 2022 (Q3 2022, Q2 2022, Q1 2022) ranging from 3.19% to 6.62%.

Overall, the trend in Pacira BioSciences Inc's net profit margin demonstrates variability, with fluctuations observed quarter to quarter. Investors and stakeholders may want to further investigate the reasons behind these fluctuations to assess the company's profitability and financial performance.